David Renzi serves as Executive at Carbylan Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Renzi has executed 6 insider transactions totaling $37.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 10, 2022 involved receiving (via award) 49,792 shares valued at $120.0K.
David Renzi currently holds 49,792 shares of Carbylan Therapeutics, Inc. (CBYL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Renzi has been a net seller of CBYL stock. They have purchased $0 and sold $37.0K worth of shares.
David Renzi's most recent insider trade was on Jun 10, 2022, when they sold 49,792 shares at $2.41 per share.
Get notified when new Form 4 filings are submitted
| $8.59 |
| Discretionary |
| Nov 21, 2016 | CBYL | $27.4K | Tender | 3,186 | $8.59 | Discretionary |
| Nov 21, 2016 | CBYL | $287.3K | Option Exercise | 36,640 | $7.84 | Discretionary |
| Dec 30, 2015 | CBYL | $5.6K | Option Exercise | 10,000 | $0.56 | Discretionary |
| Dec 30, 2015 | CBYL | $37.0K | Sale | 10,000 | $3.70 | Discretionary |